Comparison of the Structure and Function of the Retina and the Optic Nerve in Patients with a History of Multiple Sclerosis-Related Demyelinating Retrobulbar Optic Neuritis Treated and Not Treated with Systemic Steroid Therapy

References

• Optic Neuritis Study Group. The Clinical Profile of Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.Arch Ophthalmol. 1991;109(12):1673-1678. doi:10.1001/archopht.1991.01080120057025
   Google Scholar
• Dooley MC, Foroozan R. Optic neuritis. J Ophthalmic Vis Res. 2010;5:182–187.
   PubMedGoogle Scholar
• Jirawuthiworavong GV, Pecha J, Bindiganavile SH, Bhat N, Lee AG. Demyelinating optic neuritis. Available from: https://eyewiki.aao.org/Demyelinating_Optic_Neuritis. Accessed May 17, 2021.
   Google Scholar
• Plant GT. Optic neuritis and multiple sclerosis. Curr Opin Neurol. 2008;21:16–21. doi:10.1097/WCO.0b013e3282f419ca
   Web of Science ®Google Scholar
• Beck RW. The optic neuritis treatment trial. Arch Ophthalmol. 1988;106:1051. doi:10.1001/archopht.1988.01060140207023
   PubMedGoogle Scholar
• Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326:581–588. doi:10.1056/NEJM199202273260901
   PubMed Web of Science ®Google Scholar
• Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2012;4:CD001430.
   Google Scholar
• Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med. 1993;329:1764–1769. doi:10.1056/NEJM199312093292403
   PubMed Web of Science ®Google Scholar
• Robson AG, Nilsson J, Li S, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018;136:1–26. doi:10.1007/s10633-017-9621-y
   PubMed Web of Science ®Google Scholar
• Shams PN, Plant GT. Optic neuritis: a review. Int MS J. 2009;16:82–89.
   PubMedGoogle Scholar
• Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011;4:123–134. doi:10.1177/1756285611398702
   PubMedGoogle Scholar
• Mehrotra A, Jaffery N, Saxena R, Menon V. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol. 2007;55:355–359. doi:10.4103/0301-4738.33821
   Google Scholar
• Sethi H, Sharma P, Tandon R, Khokhar S, Menon V. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Indian J Ophthalmol. 2006;54:177–183. doi:10.4103/0301-4738.27069
   Google Scholar
• Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol. 1997;17:18. doi:10.1097/00041327-199703000-00004
   PubMed Web of Science ®Google Scholar
• Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh and Hoyt’s Clinical Neuro-Ophthalmology. Philadelphia: Lippincott, Williams and Wilkins; 2005.
   Google Scholar
• Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol. 2008;64:325. doi:10.1002/ana.21474
   PubMed Web of Science ®Google Scholar
• Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963. doi:10.1002/ana.20851
   PubMed Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58:383. doi:10.1002/ana.20575
   PubMed Web of Science ®Google Scholar
• Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324. doi:10.1016/j.ophtha.2005.10.040
   PubMed Web of Science ®Google Scholar
• de Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol. 2008;65:920. doi:10.1001/archneur.65.7.920
   PubMedGoogle Scholar
• Yeh EA, Marrie RA, Reginald YA, et al. Functional-structural correlations in the afferent visual pathway in pediatric demyelination. Neurology. 2014;83:2147. doi:10.1212/WNL.0000000000001046
   PubMed Web of Science ®Google Scholar
• Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain. 2001;124:468. doi:10.1093/brain/124.3.468
   PubMed Web of Science ®Google Scholar
• Hickman SJ, Toosy AT, Miszkiel KA, et al. Visual recovery following acute optic neuritis–a clinical, electrophysiological and magnetic resonance imaging study. J Neurol. 2004;251:996. doi:10.1007/s00415-004-0477-1
   PubMed Web of Science ®Google Scholar
• Celesia GG, Kaufman DI, Brigell M, et al. Optic neuritis: a prospective study. Neurology. 1990;40:919. doi:10.1212/WNL.40.6.919
   PubMed Web of Science ®Google Scholar
• Janáky M, Jánossy Á, Horváth G, Benedek G, Braunitzer G. VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis. Doc Ophthalmol. 2017;134:185–193. doi:10.1007/s10633-017-9589-7
   PubMed Web of Science ®Google Scholar
• Fraser CL, Holder GE. Electroretinogram findings in unilateral optic neuritis. Doc Ophthalmol. 2011;123:173–178. doi:10.1007/s10633-011-9294-x
   Web of Science ®Google Scholar
• Garcia-Martin E, Pueyo V, Ara JR, et al. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler. 2011;17:830–837. doi:10.1177/1352458510397414
   PubMed Web of Science ®Google Scholar
• Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40:2520–2527.
   PubMed Web of Science ®Google Scholar